Timing of Chemotherapy and Radiotherapy Following Breast-Conserving Surgery for Early-Stage Breast Cancer: A Retrospective Analysis.

Autor: Chen, Si-Ye, Tang, Yu, Wang, Shu-Lian, Song, Yong-Wen, Fang, Hui, Wang, Jian-Yang, Jing, Hao, Zhang, Jiang-Hu, Sun, Guang-Yi, Zhao, Xu-Ran, Jin, Jing, Liu, Yue-Ping, Chen, Bo, Qi, Shu-Nan, Li, Ning, Tang, Yuan, Lu, Ning-Ning, Ren, Hua, Yu, Zi-Hao, Li, Ye-Xiong
Předmět:
Zdroj: Frontiers in Oncology; 9/23/2020, Vol. 10, pN.PAG-N.PAG, 10p
Abstrakt: Purpose: To investigate the effect of chemotherapy and radiotherapy timing after breast conserving surgery (BCS) on recurrence and survival of women with early-stage breast cancer. Patients and Methods: We retrospectively analyzed 900 patients who underwent BCS followed by both adjuvant chemotherapy and radiotherapy. Of these, 488 women received chemotherapy first (CT-first group) while the other 412 received radiotherapy first (RT-first group). Locoregional recurrence (LRR), distant metastasis (DM), disease-free survival (DFS), and overall survival (OS) rates were calculated using the Kaplan-Meier method and further confirmed with propensity-score matching (PSM) and the Cox proportional hazards model. The optimal cut-off value of interval time from surgery to the start of chemotherapy was calculated by Maxstat. Results: The median follow-up was 7.1 years. In pre-match analysis, the CT-first group had a significantly higher 8-year DFS than the RT-first group (90.4% vs. 83.1%, P = 0.005). PSM analysis of 528 patients indicated that the 8-year DFS (91.0% vs. 83.3%, P = 0.005) and DM (8.6% vs. 14.6%, P = 0.017) were significantly better in the CT-first group, but that the OS (P = 0.096) and LRR (P = 0.434) were similar. We found the optimal cut-off value of interval from surgery to chemotherapy was 12 weeks. Patients starting chemotherapy later than 12 weeks after surgery had significantly inferior survival outcomes. Conclusion: For women with breast cancer who require both chemotherapy and radiotherapy after BCS, adjuvant chemotherapy should be started within 12 weeks. Delaying the initiation of radiotherapy, for administration of long-course chemotherapy, does not compromise outcomes. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index